mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0071 |
0.8 |
mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0076 |
0.8 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.0075 |
0.8 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0072 |
0.8 |
mRNA |
SNX-2112 |
GDSC1000 |
pan-cancer |
AAC |
-0.0062 |
0.8 |
mRNA |
IPA-3 |
GDSC1000 |
pan-cancer |
AAC |
-0.0068 |
0.8 |
mRNA |
KX2-391 |
CTRPv2 |
pan-cancer |
AAC |
0.0066 |
0.8 |
mRNA |
CEP-701 |
GDSC1000 |
pan-cancer |
AAC |
-0.0067 |
0.8 |
mRNA |
KIN001-260 |
GDSC1000 |
pan-cancer |
AAC |
-0.0062 |
0.8 |
mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
-0.0075 |
0.8 |